Epigenetics in cancer stem cells
- PMID: 28148257
- PMCID: PMC5286794
- DOI: 10.1186/s12943-017-0596-9
Epigenetics in cancer stem cells
Abstract
Compelling evidence have demonstrated that bulk tumors can arise from a unique subset of cells commonly termed "cancer stem cells" that has been proposed to be a strong driving force of tumorigenesis and a key mechanism of therapeutic resistance. Recent advances in epigenomics have illuminated key mechanisms by which epigenetic regulation contribute to cancer progression. In this review, we present a discussion of how deregulation of various epigenetic pathways can contribute to cancer initiation and tumorigenesis, particularly with respect to maintenance and survival of cancer stem cells. This information, together with several promising clinical and preclinical trials of epigenetic modulating drugs, offer new possibilities for targeting cancer stem cells as well as improving cancer therapy overall.
Keywords: Cancer stem cells; DNA methylation; Epigenetics; Histone methylation; Histone methyltransferase; Signaling pathway.
Figures

Similar articles
-
Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.Clin Epigenetics. 2021 May 29;13(1):120. doi: 10.1186/s13148-021-01107-4. Clin Epigenetics. 2021. PMID: 34051847 Free PMC article. Review.
-
Epigenetic Targets and their Inhibitors in Cancer Therapy.Curr Top Med Chem. 2018;18(28):2395-2419. doi: 10.2174/1568026619666181224095449. Curr Top Med Chem. 2018. PMID: 30582481 Review.
-
[Targeted epigenetic therapy of cancer. Achievements and perspectives].Cir Cir. 2012 Sep-Oct;80(5):470-80. Cir Cir. 2012. PMID: 23351455 Review. Spanish.
-
Epigenetic regulation of cancer stem cell formation and maintenance.Int J Cancer. 2021 Jun 15;148(12):2884-2897. doi: 10.1002/ijc.33398. Epub 2020 Nov 30. Int J Cancer. 2021. PMID: 33197277 Free PMC article. Review.
-
Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?Mol Cancer. 2006 Jul 10;5:27. doi: 10.1186/1476-4598-5-27. Mol Cancer. 2006. PMID: 16831224 Free PMC article.
Cited by
-
DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling.Mol Cancer Res. 2023 Feb 1;21(2):140-154. doi: 10.1158/1541-7786.MCR-22-0418. Mol Cancer Res. 2023. PMID: 36318113 Free PMC article.
-
Helicobacter pylori Virulence Factor Cytotoxin-Associated Gene A (CagA)-Mediated Gastric Pathogenicity.Int J Mol Sci. 2020 Oct 8;21(19):7430. doi: 10.3390/ijms21197430. Int J Mol Sci. 2020. PMID: 33050101 Free PMC article. Review.
-
Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.Cells. 2020 Aug 13;9(8):1896. doi: 10.3390/cells9081896. Cells. 2020. PMID: 32823711 Free PMC article. Review.
-
Biological Functions of the ING Proteins.Cancers (Basel). 2019 Nov 19;11(11):1817. doi: 10.3390/cancers11111817. Cancers (Basel). 2019. PMID: 31752342 Free PMC article. Review.
-
The paradigm of drug resistance in cancer: an epigenetic perspective.Biosci Rep. 2022 Apr 29;42(4):BSR20211812. doi: 10.1042/BSR20211812. Biosci Rep. 2022. PMID: 35438143 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources